Early initiation of treatment with Candesartan vs Placebo in genetic carriers of causative DCM mutations without evidence of disease (EARLY-GENE trial)
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: FOUNDATION FOR BIOMEDICAL RESEARCH OF THE PUERTA DE HIERRO MAJADAHONDA UNIVERSITY HOSPITAL
- Phase: III
- Execution start: 30/03/2022
- End of execution: 30/05/2026
- IP: JUAN JIMENEZ JAIMEZ